BETHESDA, Md. (MedPage Today) -- The National Heart, Lung, and Blood Institute (NHLBI) has terminated a clinical trial of concentrated saline for trauma patients in shock, after interim results indicated no benefit for the treatment.
Lack of Efficacy Forces Halt to Shock Treatment StudyCourtesy MedPage Today Emergency Medicine Thu, 03/26/2009 - 09:06
BETHESDA, Md. (MedPage Today) -- The National Heart, Lung, and Blood Institute (NHLBI) has terminated a clinical trial of concentrated saline for trauma patients in shock, after interim results indicated no benefit for the treatment. Tags:
More related itemsIn the News: Resveratrol
Treatment of silent acid reflux does not improve...
Quality Checklist Doesn't Assure Outcome (CME/CE)
|
Popular by tags WeekMonth |
Post new comment